Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Next Generation Sequencing Companies

Next Generation Sequencing companies are at the forefront of genomic advancements. Specializing in research, development, and distribution, these organizations provide cutting-edge sequencing technologies, revolutionizing genomic analysis and contributing to advancements in personalized medicine and genetic research.

next generation market

Latest Next Generation Sequencing Companies Updates:

S2 Genomics: Raised $16 million in Series A funding to accelerate the commercial adoption of their single-cell or -nuclei sample preparation platform for solid tissues.

Caris Life Sciences (NASDAQ: CAR): Initiated a Phase 2 clinical trial evaluating their Precision Oncology 9 Genomic Sequencing Assay in conjunction with their Caris Precision Medicine Therapy™ for advanced head and neck cancer patients.

Illumina (ILMN): Launched a Phase 2 study evaluating their NGS-based liquid biopsy assay for detecting minimal residual disease in early-stage breast cancer patients after neoadjuvant therapy.

Thermo Fisher Scientific (TMO): Acquired PacBio, a leading developer of single-molecule sequencing technology, expanding their NGS portfolio and offering improved long-read sequencing capabilities.

Illumina: Partnered with BioMarin Pharmaceutical (BMRN) to develop and commercialize NGS-based companion diagnostics for BioMarin's gene therapy treatments.Agilent Technologies (A): Entered into a collaboration with Guardant Health (GH) to combine their respective strengths in NGS and liquid biopsy technologies for early cancer detection and monitoring.

List of Next Generation Sequencing companies in the market:

Becton Eurofins Scientific (US)

Illumina, Inc. (US)

Genome Life Sciences (India)

GenScript (US)

Thermo Fisher Scientific, Inc. (US)

Qiagen (Germany)

PerkinElmer, Inc. (US)

F. Hoffmann-La Roche Ltd (Switzerland)

Pacific Biosciences of California, Inc. (US)

Next Generation Sequencing Market Highlights:

Next Generation Sequencing Market Size

Next Generation Sequencing Market Trends

Next Generation Sequencing Market Analysis

Next Generation Sequencing Market Share

Next Generation Sequencing Market Highlights:

Next Generation Sequencing Market Trends

Next Generation Sequencing Market Analysis

Next Generation Sequencing Market Share

Next Generation Sequencing Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.